Cargando…
Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat‐inhibited Dopamine Transport
HIV-1 transactivator of transcription (Tat) has a great impact on the development of HIV-1 associated neurocognitive disorders through disrupting dopamine transmission. This study determined the mutational effects of human dopamine transporter (hDAT) on basal and Tat-induced inhibition of dopamine t...
Autores principales: | Quizon, Pamela M., Yuan, Yaxia, Zhu, Yike, Zhou, Yi, Strauss, Matthew J., Sun, Wei-Lun, Zhan, Chang-Guo, Zhu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329121/ https://www.ncbi.nlm.nih.gov/pubmed/33537927 http://dx.doi.org/10.1007/s11481-021-09984-5 |
Ejemplares similares
-
Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport
por: Sun, Wei-Lun, et al.
Publicado: (2019) -
Role of Histidine 547 of Human Dopamine Transporter in Molecular Interaction with HIV-1 Tat and Dopamine Uptake
por: Yuan, Yaxia, et al.
Publicado: (2016) -
Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport
por: Quizon, Pamela M., et al.
Publicado: (2016) -
Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter
por: Sun, Wei-Lun, et al.
Publicado: (2017) -
Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function
por: Strauss, Matthew J., et al.
Publicado: (2022)